Literature DB >> 22709631

Methamphetamine influences on brain and behavior: unsafe at any speed?

John F Marshall1, Steven J O'Dell.   

Abstract

Methamphetamine damages monoamine-containing nerve terminals in the brains of both animals and human drug abusers, and the cellular mechanisms underlying this injury have been extensively studied. More recently, the growing evidence for methamphetamine influences on memory and executive function of human users has prompted studies of cognitive impairments in methamphetamine-exposed animals. After summarizing current knowledge about the cellular mechanisms of methamphetamine-induced brain injury, this review emphasizes research into the brain changes that underlie the cognitive deficits that accompany repeated methamphetamine exposure. Novel approaches to mitigating or reversing methamphetamine-induced brain and behavioral changes are described, and it is argued that the slow spontaneous reversibility of the injury produced by this drug may offer opportunities for novel treatment development.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22709631      PMCID: PMC3432170          DOI: 10.1016/j.tins.2012.05.006

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  103 in total

Review 1.  Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: neurotoxic and therapeutic implications.

Authors:  Annette E Fleckenstein; Trent J Volz; Glen R Hanson
Journal:  Neuropharmacology       Date:  2008-07-10       Impact factor: 5.250

2.  Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers.

Authors:  Yang-Tae Kim; Sang-Woo Lee; Do-Hoon Kwon; Ji-Hyoung Seo; Byeong-Cheol Ahn; Jaetae Lee
Journal:  J Psychiatr Res       Date:  2009-04-23       Impact factor: 4.791

3.  Cortical activation during delay discounting in abstinent methamphetamine dependent individuals.

Authors:  William F Hoffman; Daniel L Schwartz; Marilyn S Huckans; Bentson H McFarland; Gal Meiri; Alexander A Stevens; Suzanne H Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2008-08-07       Impact factor: 4.530

Review 4.  Molecular bases of methamphetamine-induced neurodegeneration.

Authors:  Jean Lud Cadet; Irina N Krasnova
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

5.  Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion.

Authors:  Marek Schwendt; Angelica Rocha; Ronald E See; Alejandra M Pacchioni; Jacqueline F McGinty; Peter W Kalivas
Journal:  J Pharmacol Exp Ther       Date:  2009-07-31       Impact factor: 4.030

6.  Brain serotonin transporter in human methamphetamine users.

Authors:  Stephen J Kish; Paul S Fitzmaurice; Isabelle Boileau; Gregory A Schmunk; Lee-Cyn Ang; Yoshiaki Furukawa; Li-Jan Chang; Dennis J Wickham; Allan Sherwin; Junchao Tong
Journal:  Psychopharmacology (Berl)       Date:  2008-10-08       Impact factor: 4.530

7.  Prospective memory impairment in former users of methamphetamine.

Authors:  Peter G Rendell; Magdalena Mazur; Julie D Henry
Journal:  Psychopharmacology (Berl)       Date:  2008-11-27       Impact factor: 4.530

Review 8.  Mechanisms and targets for angiogenic therapy after stroke.

Authors:  Deepti Navaratna; Shuzhen Guo; Ken Arai; Eng H Lo
Journal:  Cell Adh Migr       Date:  2009-04-13       Impact factor: 3.405

9.  Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine.

Authors:  Alicia Izquierdo; Annabelle M Belcher; Lori Scott; Victor A Cazares; Jack Chen; Steven J O'Dell; Melissa Malvaez; Tiffany Wu; John F Marshall
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  Drug abstinence and cognitive control in methamphetamine-dependent individuals.

Authors:  Ruth Salo; Thomas E Nordahl; Gantt P Galloway; Charles D Moore; Christy Waters; Martin H Leamon
Journal:  J Subst Abuse Treat       Date:  2009-03-31
View more
  36 in total

1.  Preliminary evaluation of a model of stimulant use, oxidative damage and executive dysfunction.

Authors:  Theresa Winhusen; Jessica Walker; Gregory Brigham; Daniel Lewis; Eugene Somoza; Jeff Theobald; Veronika Somoza
Journal:  Am J Drug Alcohol Abuse       Date:  2013-06-28       Impact factor: 3.829

2.  Melatonin Protects Methamphetamine-Induced Neuroinflammation Through NF-κB and Nrf2 Pathways in Glioma Cell Line.

Authors:  Pichaya Jumnongprakhon; Piyarat Govitrapong; Chainarong Tocharus; Decha Pinkaew; Jiraporn Tocharus
Journal:  Neurochem Res       Date:  2015-05-22       Impact factor: 3.996

3.  Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes.

Authors:  Irma E Cisneros; Anuja Ghorpade
Journal:  Neuropharmacology       Date:  2014-06-17       Impact factor: 5.250

4.  Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.

Authors:  John D Robinson; Christopher D Howard; Elissa D Pastuzyn; Diane L Byers; Kristen A Keefe; Paul A Garris
Journal:  Neurotox Res       Date:  2014-02-22       Impact factor: 3.911

5.  Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens.

Authors:  Kequan Fu; Huiyang Lin; Yoshiaki Miyamoto; Chunfu Wu; Jingyu Yang; Kyosuke Uno; Atsumi Nitta
Journal:  Psychopharmacology (Berl)       Date:  2015-12-01       Impact factor: 4.530

6.  Failure to Recognize Novelty after Extended Methamphetamine Self-Administration Results from Loss of Long-Term Depression in the Perirhinal Cortex.

Authors:  Michael D Scofield; Heather Trantham-Davidson; Marek Schwendt; Kah-Chung Leong; Jamie Peters; Ronald E See; Carmela M Reichel
Journal:  Neuropsychopharmacology       Date:  2015-04-13       Impact factor: 7.853

7.  Incubation of methamphetamine and palatable food craving after punishment-induced abstinence.

Authors:  Irina N Krasnova; Nathan J Marchant; Bruce Ladenheim; Michael T McCoy; Leigh V Panlilio; Jennifer M Bossert; Yavin Shaham; Jean L Cadet
Journal:  Neuropsychopharmacology       Date:  2014-03-03       Impact factor: 7.853

8.  Hydrogen Sulfide Protects Hippocampal Neurons Against Methamphetamine Neurotoxicity Via Inhibition of Apoptosis and Neuroinflammation.

Authors:  Fateme Ghanbari; Mehdi Khaksari; Golamhassan Vaezi; Vida Hojati; Abdolhossein Shiravi
Journal:  J Mol Neurosci       Date:  2018-11-19       Impact factor: 3.444

9.  Role of methamphetamine on glioblastoma cytotoxicity induced by doxorubicin and methotrexate.

Authors:  Tânia Capelôa; Francisco Caramelo; Carlos Fontes-Ribeiro; Célia Gomes; Ana P Silva
Journal:  Neurotox Res       Date:  2014-03-21       Impact factor: 3.911

Review 10.  Chronic methamphetamine self-administration disrupts cortical control of cognition.

Authors:  Aurelien Bernheim; Ronald E See; Carmela M Reichel
Journal:  Neurosci Biobehav Rev       Date:  2016-07-20       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.